Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies

NCT00241358 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Myeloid, Acute
Leukemia, Myelogenous, Chronic
Leukemia, Lymphoblastic, Acute
Lymphocytic Leukemia, Chronic
Myelodysplastic Syndromes
Multiple Myeloma
Lymphoma, Non-Hodgkin
Hodgkin Disease

Interventions

DRUG: AMD3100
PROCEDURE: Stem Cell Transplant

Sponsor

Washington University School of Medicine